MYC and lymphoma: Perhaps the most direct evidence to support the role of eIF4E phosphorylation in cancer was obtained from a series of eIF4E or MNK1/2 mutants which were used to test their contribution to the lymphoma tumorigenesis in the Eμ-Myc transgenic mouse lymphoma model [82].